Results 11 to 20 of about 605 (131)

Progesterone levels on the day of embryo transfer using a single pessary of 400mg of vaginal progesterone vs. 200mg x2 pessaries in hormonal replacement cycles. [PDF]

open access: yesJBRA Assist Reprod, 2023
Does the use of 400mg pessaries of micronized progesterone provide comparable results as pessaries of 200mg x2, in terms of progesterone levels in hormonal replacement cycles for embryo transfer?.Retrospective cohort study based on 299 embryo transfer treatments under artificial endometrial preparation carried out at Instituto Bernabeu.
Herencia A   +7 more
europepmc   +3 more sources

High Dose Corticosteroids in Chronic Histiocytic Intervillositis Allowing Prolongation of Pregnancy: A Case Report. [PDF]

open access: yesJ Obstet Gynaecol Res
ABSTRACT Chronic histiocytic intervillositis (CHI) is a rare placental disorder linked to poor pregnancy outcomes, including fetal growth restriction and perinatal loss. We report a case of recurrent CHI in a 36‐year‐old woman with five previous pregnancy losses. In her sixth pregnancy, placental histology confirmed CHI after preterm delivery.
Dave A   +5 more
europepmc   +2 more sources

Trends in Government-Subsidised Menopausal Hormone Therapy Dispensing in Australia Between 2014 and 2023. [PDF]

open access: yesAust N Z J Obstet Gynaecol
ABSTRACT Menopausal hormone therapy (MHT) is a mainstay treatment for menopausal symptoms. While international studies report rising MHT use, trends in Australia remain unclear. Using a 10% random sample of Pharmaceutical Benefits Scheme (PBS) data from 2014 to 2023, we analysed the prevalence of MHT dispensing among women aged 45–64.
Risni HW   +5 more
europepmc   +2 more sources

Common Gynecologic Issues in Patients Post-Kidney Transplantation. [PDF]

open access: yesClin Transplant
ABSTRACT Advances in kidney transplantation have transformed survival and quality of life for women with end‐stage renal disease, necessitating a focus on long‐term health care for this population. Female kidney transplant recipients (KTR) experience a unique spectrum of gynecologic issues shaped by persistent hormonal dysregulation, lifelong ...
Graham ME   +4 more
europepmc   +2 more sources

Cervical pessary versus vaginal progesterone in women with a multiple pregnancy and a short cervix: A randomised controlled trial. [PDF]

open access: yesPLoS Med
Background In absence of direct comparisons, consensus on the preferred preventive treatment for multiple pregnancies with a short cervix is lacking. Therefore, we compared the effectiveness of a cervical pessary and vaginal progesterone in the prevention of adverse perinatal outcomes and preterm birth (PTB) in ...
van Dijk CE   +19 more
europepmc   +9 more sources

Effect of the Arabin pessary and natural progesterone on the vaginal microbiome

open access: yes, 2023
Abstract Background Preterm birth is a leading cause of infant morbidity and mortality. Regardless of its multifactorial nature, it has been demonstrated that vaginal infections, as well instability of the local microbiome, can play a role as risk factors.
Antonio G Amorim-Filho   +6 more
openaire   +1 more source

Progesterone for Luteal Phase Support in in Vitro Fertilization: Comparison of Vaginal and Rectal Pessaries to Vaginal Capsules: A Randomized Controlled Study [PDF]

open access: yesClinical Medicine Insights: Women's Health, 2016
Background In IVF, Luteal phase support is usually performed using vaginal progesterone. A part of patients using this route reports being uncomfortable with this route. We tried to study whether the rectal route could be an effective alternative and associated with less discomfort. Patients and Methods A prospective randomized controlled study.
Khrouf, Mohamed   +10 more
openaire   +2 more sources

Vaginal progesterone combined with cervical pessary in preventing preterm birth: a meta-analysis

open access: yesThe Journal of Maternal-Fetal & Neonatal Medicine, 2019
Vaginal progesterone and cervical pessary are both shown to be effective in preventing preterm. We conducted a meta-analysis to evaluate whether the combination of these two interventions has any additional benefit in preventing preterm birth and improving perinatal outcomes in asymptomatic women with a singleton gestation who had a midtrimester ...
Jing Liu, Guang Song, Tao Meng, Ge Zhao
openaire   +2 more sources

Efficacy, safety and tolerability of progesterone vaginal pessaries versus progesterone vaginal gel for luteal phase support after in vitro fertilisation: a randomised controlled trial

open access: yesHuman Reproduction, 2020
Abstract STUDY QUESTION Are progesterone vaginal pessaries 400 mg twice a day (bid) non-inferior to progesterone vaginal gel (90 mg) once a day (od) in the primary endpoint of clinical pregnancy rate after 38 days of luteal phase support in women undergoing in vitro fertilisation (IVF)?
Saunders, Helen   +5 more
openaire   +2 more sources

Progesterone after previous preterm birth for prevention of neonatal respiratory distress syndrome (PROGRESS): a randomised controlled trial

open access: yesBMC Pregnancy and Childbirth, 2009
Background Neonatal respiratory distress syndrome, as a consequence of preterm birth, is a major cause of early mortality and morbidity during infancy and childhood.
Flenady Vicki   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy